Alps Group Inc (ALPS)
NASDAQ: ALPS · Real-Time Price · USD
0.938
+0.018 (1.95%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Alps Group Market Cap
Alps Group has a market cap or net worth of $156.07 million as of April 28, 2026. Its market cap has increased by 75.02% in one year.
Market Cap
156.07M
Enterprise Value
156.20M
1-Year Change
75.02%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since December 23, 2021, Alps Group's market cap has increased from $143.00M to $156.07M, an increase of 9.14%. That is a compound annual growth rate of 2.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 153.09M | 5.82% |
| Dec 31, 2025 | 144.67M | 230.19% |
| Dec 30, 2024 | 43.81M | -50.64% |
| Dec 29, 2023 | 88.76M | -41.77% |
| Dec 30, 2022 | 152.44M | 6.93% |
| Dec 30, 2021 | 142.56M | -0.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jyong Biotech | 165.34M |
| Tiziana Life Sciences | 160.81M |
| Molecular Partners AG | 159.72M |
| Agenus | 157.05M |
| ProQR Therapeutics | 156.99M |
| Galectin Therapeutics | 156.01M |
| Spero Therapeutics | 154.57M |
| Spruce Biosciences | 154.52M |